Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Research use differs from medical use because a laboratory or preclinical study does not establish an approved human treatment
Triple peptides for the treatment of obesity Retatrutide, a single peptide linked to a fatty diacid moiety, acts as a triple-agonist targeting three receptors: GIP, GLP-1, and glucagon
Both medications are commonly prescribed for managing type 2 diabetes and can be used in combination when a single drug doesn't provide adequate blood sugar control
Case Studies: 3 Paths, 3 Sets of Results Note: These are illustrative examples
US$ 21.08
US$ 24.11
US$ 26.78
US$ 26.68
US$ 28.49
US$ 27.73
